Abstract
MITF (m icrophthalmia–associated transcription factor) encodes a transcription factor with a basic–helix–loop–helix–zipper (bHLH–Zip) motif. MITF mutations occur in patients with Waardenburg syndrome type 2, a disorder associated with melanocyte abnormalities. Here we show that ectopic expression of MITF converts NIH/3T3 fibroblasts into cells with characteristics of melanocytes. MITF transfectants formed foci of morphologically altered cells, which resemble those induced by oncogenes, but did not exhibit malignant phenotypes. Instead, they contained dendritic cells that express melanogenic marker proteins such as tyrosinase and tyrosinase–related protein 1. Most cloned cells of MITF transfectants exhibited dendritic morphology and expressed melanogenic markers, but such properties were not observed in cells transfected with closely related TFE3 cDNA. Our findings indicate that MITF is critically involved in melanocyte differentiation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hodgkinson, C.A. et al. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell 74, 395–404 (1993).
Steingrimsson, E. et al. Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences. Nature Genet. 8, 256–263 (1994).
Silvers, W.K. Microphthalmia and other considerations. in The coat colors of mice. 268–332 (Springer-Vertag, 1979).
Tachibana, M. et al. Cochlear disorder associated with melanocyte anomaly in mice with a transgente insertional mutation. Mol. Cell. Neurosci. 3, 433–445 (1992).
Asher, J.H. Jr. & Friedman, T.B. Mouse and hamster mutants as models for Waardenburg syndrome in humans. J. Med. Genet. 27, 618–626 (1990).
Arias, S. Genetic heterogeneity in the Waardenburg syndrome. Birth Defects: Original Article Series 7, 87–101 (1971).
McKusick, V.A. Mendelian Inheritance in Man. 10th edn. (Johns Hopkins University Press, Baltimore, Maryland, 1992).
Farrer, L.A. et al. Waardenburg syndrome (WS) type I is caused by defects at multiple loci, one of which is near ALPP on chromosome 2: First report of the WS consortium. Am. J. Hum. Genet. 50, 902–913 (1992).
Klein, D. Historical background and evidence for dominant inheritance of the Klein-Waardenburg syndrome (type III). Am. J. Med. Genet. 14, 231–239 (1983).
Shah, K.N. et al. White forelock, pigmentary disorder of irides, and long segment Hirschsprung disease; possible variant of Waardenburg syndrome. J. Pediat. 99, 432–435 (1981).
Tassabehji, M. et al. Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene. Nature 355, 635–636 (1992).
Baldwin, C.T., Hoth, C.F., Amos, J.A., da-Silva, E.O. & Milunsky, A. An exonic mutation in the Hup2 paired domain gene causes Waardenburg's syndrome. Nature 355, 637–638 (1992).
Hoth, C.F., Milunsky, A., Lipsky, N., Scheffer, R., Clarren, S.K. & Balwin, C.T. Mutations in the paired domain of the human PAX3 gene cause KleinWaardenburg syndrome (WS-lll) as well as Waardenburg syndrome type I (WS-I). Am. J. Hum. Genet. 52, 455–462, (1993).
Chalepakis, G., Goulding, M., Read, A., Strachan, T. & Gruss, P. Molecular basis of splotch and Waardenburg Pax-3 mutations. Proc. Natl. Acad. Sci. USA 91, 3685–3689 (1994).
Strachan, T. & Read, A.P. PAX genes. Curr. Opin. Genet. Dev. 4, 427–438, (1994).
Tassabehji, M. et al. The mutational spectrum in Waardenburg syndrome. Hum. Mol. Genet. 4, 2131–2137 (1995).
Read, A.P. & Newton, V. Mutations of PAX3 unlikely in Waardenburg syndrome type 2. Nature Genet. 5, 8 (1993).
Tassabehji, M., Newton, V.E. & Read, A.P. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nature Genet. 8, 251–255 (1994).
Nobukuni, Y., Watanabe, A., Takeda, K., Skarka, H. & Tachibana, M. Analyses of loss-of-function mutations of the MITF gene suggest that haploinsufficinency is a cause of Waardenburg syndrome type 2A. Am. J. Hum. Genet. 59, 76–83 (1996).
Tachibana, M. et al. Cloning of MITF, the human homolog of the mouse microphthalmia gene and assignment to chromosome 3p14. 1–p12.3. Hum. Mol. Genet. 3, 553–557 (1994).
Nakashima, S., Sando, I., Takahashi, H. & Hashida, Y. Temporal bone histopathologic findings of Waardenburg syndrome: A case report. Laryngoscope 102, 563–567 (1992).
Davis, R.L., Weintraub, H. & Lassar, A.B. Expression of single transfected cDNA converts fibroblasts to myoblasts. Cell 51, 987–1000 (1987).
Weintraub, H. et al. The myoD gene family: Nodal point during specification of the muscle cell lineage. Science 261, 761–766 (1991).
Tontonoz, P., Kim, J.B., Graves, R.A. & Spiegelrnan, B.M. ADD1: a novel helixloop-helix transcription factor associated with adipocyte determination and differentiation. Mol. Cell. Biol. 13, 4753–4759 (1993).
Miki, T. et al. Development of a highly efficient expression cDNA cloning system: Application to oncogene isolation. Proc. Natl Acad. Sci. USA 88, 5167–5171 (1991).
Winder, A.J. Expression of a mouse tyrosinase cDNA in 3T3 Swiss mouse flbroblasts. Biochem. Biophys. Res. Comm. 178, 739–745 (1991).
Bouchard, B., Fuller, B.B., Vijayasaradhi, S. & Hougnton, A.N. Induction of pigmentation in mouse fibroblasts by expression of human tyrosinase cDNA. J. Exp. Med. 169, 2029–2042 (1989).
Jainchill, J.L., Aaronson, S.A. & Todaro, G.J. Murine sarcoma and leukemia viruses: Assay using clonal lines of contact-inhibited mouse cells. J. Virol. 4, 549–553 (1969).
Yokoyama, T. et al. Conserved cysteine to serine mutation in tyrosinase is responsible for the classical albino mutation in laboratory mice. Nucl. Acid Res. 18, 7293–7298 (1990).
Hearing, V.J. & Ekel, T.M. Mammalian tyrosinase. A comparison of tyrosine hydroxylation and melanin formation. Biochem. J. 157, 549–557 (1976).
Jiménez, M., Tsukamoto, K. & Hearing, V.J. Tyrosinase from two different loci are expressed by normal and by transformed melanocytes. J. Biol. Chem. 266, 1147–1156 (1991).
Jiménez, M., Maloy, W.L. & Hearing, V.J. Specific identification of an authentic clone for mammalian tyrosinase. J. Biol. Chem. 264, 3397–3403 (1989).
Tsukamoto, K., Jackson, I.J., Urabe, K., Montague, P.M. & Hearing, V.J. A second tyrosinase-related protein, TRP-2, is a melanogenic enzyme termed DOPAchrometautomerase. EMBO J. 11, 519–526 (1992).
Horii, Y., Beeler, J.F., Sakaguchi, K., Tachibana, M. & Miki, T. Anovel oncogene, ost, encodes a guanine nucleotide exchange factor that potentially links Rho and Rac signaling pathways. EMBO J. 13, 4776–4786 (1994).
Beckmann, H., Su, L.-K. & Kadesch, T. TFE3: a helix-loop-helix protein that activates transcription through the immunoglobulin enhancer μE3 motif. Genes Dev. 4, 167–179 (1990).
Carr, C.S. & Sharp, P.A. A helix-loop-helix protein related to the immunoglobulin E box-binding proteins. Mol. Cell. Biol. 10, 4384–4388 (1990).
Zhao, G.-Q., Zhao, Q., Zhou, X., Mattei, M.-G. & DeCrombrugghe, B. TFEC, a basic helix-ioop-helix protein, forms heterodimers with TFE3 and inhibits TFE3-dependent transcription activation. Mol. Cell. Biol. 13, 4505–4512 (1993).
Hemesath, T.J. et al. Microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev. 8, 2770–2780 (1994).
Puck, T.T. & Marcus, P.I. A rapid method for viable cell titration and clone production with HeLa cells in tissue culture: The use of X-irradiated cells to supply conditioning factors. Proc. Nail. Acad. Sci. USA 41, 432–437 (1955).
Peters, T.A., Kuijpers, W., Tonnaer, E.L., van Muijen, G.N. & Jap, P.H. Distribution and features of melanocytes during inner ear development in pigmented and albino rats. Hear. Res. 85, 169–180 (1995).
Keithley, E.M., Ryan, A.F. & Feldman, M.L. Cochlear degeneration in aged rats of four strains. Hear. Res. 59, 171–178 (1992).
Bentley, N.J., Eisen, T. & Goding, C.R. Melanocyte-specific expression of the human tyrosinase promoter: Activation by the microphthalmia gene product and roleoftheinitiator. Mol. Cell. Biol. 14, 7996–8006 (1994).
Yasumoto, K. et al. Microphthalmra-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene. Mol. Cell. Biol. 14, 8058–8070 (1994).
Yavuzer, U. et al. The Microphthalmia gene product interacts with retinoblastoma protein in vitro and is a target for deregulation of melanocyte-specific transcription. Oncogene 10, 123–134 (1995).
Donatien, P., Surieve-Bazeille, J.E., Thody, A.J. & Taieb, A. Growth and differentiation of normal human melanocytes in a TPA-free, cholera toxin-free, low serum medium and influence of keratinocytes. Arch. Dermatol. Res. 285, 385–392 (1993).
Guarini, L. et al. Modulation of the antigenic phenotype of human melanoma cells by differentiation-inducing and growth-suppressing agents. Pigment Cell Res. 2, 123–131 (1992).
Olson, E.N. et al. Molecular control of myogenesis: antagonism between growth and differentiation. Mol. Cell. Biochem. 104, 7–13 (1991).
Thayer, M.J. & Weintraub, H. Activation and repression of myogenesis in somatic cell hybrids: evidence for trans-negative regulation of MyoD in primary fibroblasts. Cell 63, 23–32 (1990).
Woloshin, P. et al. MSX1 inhibits myoD expression in fibroblast × 10T1/2 cell hybrids. Cell 82, 611–620 (1995).
Powers, T.P., Shows, T.B. & Davidson, R.L. Pigment-cell-specific gene from fibroblasts are transactivated after chromosomal transfer into melanoma cells. Mol. Cell. Biol. 14, 1179–1190 (1994).
Davidson, R., Ephrussi, B. & Yamamoto, K. Regulation of melanin synthesis in mammalian cells, as studied by somatic hybridization. I. Evidence for negative control. J. Cell. Physiol. 127, 115–128 (1968).
Davidson, R. & Yamamoto, K. Regulation of melanin synthesis in mammalian cells, as studied by somatic hybridization. II. The level of regulation of 3,4 dihydroxyphenylalanine oxidase. Proc. Natl. Acad. Sci USA 60, 894–901 (1968).
Junker, S. Persistence, suppression and re-expression of pigment formation in somatic cell hybrids between mouse melanoma cells and non-melanoma cells. J. Cell Sci. 47, 207–226 (1981).
Hughes, A.E., Newton, V.E., Liu, X.Z. & Read, A.P. A gene for Waardenburg syndrome type 2 maps close to the human homologue of the microphthalmia gene at chromosome 3p12–p 14.1. Nature Genet. 7, 509–512 (1994).
Tamura, M. & Noda, M. Identification of a DNA sequence involved in osteoblast-specific gene expression via interaction with helix-loop-heiix (HLH)-typetranscriptionfactors. J. Cell. Biol. 126, 773–782 (1994).
Murre, C. & Baltimore, D. The helix-loop-helix motif: structure and function. in Transcrptional Regulations (eds S.L. McKnight & K.R. Yamamoto) 861–879 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1992).
Jarman, A.P., Grau, Y., Jan, L.Y. & Jan, Y.N. Atonal is a proneural gene that directs chordotonal organ formation in the Drosophila peripheral nervous system. Cell 73, 1307–1321 (1993).
Dominguez, M. & Campuzano, S. Asense, a member of Drosophila achaetescute complex, is a proneural and neural differentiation gene. EMBO J. 12, 2049–2060 (1993).
Guillemot, F. et al. Mammalian achaete-scute homolog 1 is required for the early development of olfactory and autonomic neurons. Cell 75, 463–476 (1993).
Wigler, M. et al. Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells. Cell 11, 223–232 (1977).
Aroca, P., Urabe, K., Kobayashi, T., Tsukamoto, K. & Hearing, V.J. Melanin biosynthesis patterns following hormonal stimulation. J. Biol. Chem. 268, 25650–25655 (1993).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tachibana, M., Takeda, K., Nobukuni, Y. et al. Ectopic expression of MITF, a gene for Waardenburg syndrome type 2, converts fibroblasts to cells with melanocyte characteristics. Nat Genet 14, 50–54 (1996). https://doi.org/10.1038/ng0996-50
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng0996-50
This article is cited by
-
MITF variants cause nonsyndromic sensorineural hearing loss with autosomal recessive inheritance
Scientific Reports (2020)
-
Loss of tumorigenic potential upon transdifferentiation from keratinocytic into melanocytic lineage
Scientific Reports (2016)
-
Dual effects of acetylsalicylic acid on ERK signaling and Mitf transcription lead to inhibition of melanogenesis
Molecular and Cellular Biochemistry (2016)
-
Deep in vivo photoacoustic imaging of mammalian tissues using a tyrosinase-based genetic reporter
Nature Photonics (2015)
-
Effect of quercetin derivatives on melanogenesis stimulation of melanoma cells
Journal of Wood Science (2015)